Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A current clinical diagnosis of COPD with COPD symptoms for more than 2 years~* Current smoker or smoking history of 10 or more pack years (1 pack year = 20 cigarettes smoked per day for one year)~* A history of at least 1 COPD exacerbations requiring a course of steroids and/or antibiotics within 1-12 months before the first visit~Exclusion Criteria:~* A history of asthma at or after 18 years of age~* A history of allergic rhinitis at or after 18 years of age~* Subjects taking oral steroids~* Any significant disease or disorder that may jeopardize a subject's safety

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).